Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
29
MED Quote, Financials, Valuation and Earnings
Last price:
$11.32
Seasonality move
:
11.84%
Day range:
$11.12 - $11.32
52-week range:
$10.36 - $18.59
Dividend yield:
0%
P/E ratio:
533.49x
P/S ratio:
0.29x
P/B ratio:
0.57x
Volume:
197.2K
Avg. volume:
258.7K
1-year change:
-33.53%
Market cap:
$122.6M
Revenue:
$602.5M
EPS (TTM):
$0.02
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | |
| Revenue Growth (YoY) | 30.99% | 63.25% | 4.75% | -32.94% | -43.8% | |
| Cost of Revenues | $237M | $398.5M | $446M | $296.2M | $157.8M | |
| Gross Profit | $697.8M | $1.1B | $1.2B | $775.9M | $444.6M | |
| Gross Profit Margin | 74.65% | 73.89% | 72.1% | 72.37% | 73.8% | |
| R&D Expenses | $2.8M | $4.4M | $4.5M | $4.6M | $4.6M | |
| Selling, General & Admin | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | |
| Other Inc / (Exp) | -$140K | $119K | -$46K | -$95K | -$3.9M | |
| Operating Expenses | $563.7M | $911.4M | $936.6M | $649.4M | $441.7M | |
| Operating Income | $134.2M | $216.2M | $216M | $126.4M | $2.9M | |
| Net Interest Expenses | -- | $231K | $701K | -- | -- | |
| EBT. Incl. Unusual Items | $134.3M | $216.1M | $184.1M | $128.8M | $3.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $31.4M | $52.1M | $40.5M | $29.4M | $1.7M | |
| Net Income to Company | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Basic EPS (Cont. Ops) | $8.74 | $14.01 | $12.82 | $9.13 | $0.19 | |
| Diluted EPS (Cont. Ops) | $8.68 | $13.89 | $12.73 | $9.10 | $0.19 | |
| Weighted Average Basic Share | $11.8M | $11.7M | $11.2M | $10.9M | $10.9M | |
| Weighted Average Diluted Share | $11.9M | $11.8M | $11.3M | $10.9M | $11M | |
| EBITDA | $141.4M | $228.1M | $233.1M | $144.1M | $20.3M | |
| EBIT | $134.2M | $216.2M | $216M | $126.4M | $2.9M | |
| Revenue (Reported) | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | |
| Operating Income (Reported) | $134.2M | $216.2M | $216M | $126.4M | $2.9M | |
| Operating Income (Adjusted) | $134.2M | $216.2M | $216M | $126.4M | $2.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $413.4M | $390.4M | $235.9M | $140.2M | $89.4M | |
| Revenue Growth (YoY) | 52.28% | -5.56% | -39.58% | -40.58% | -36.21% | |
| Cost of Revenues | $106.3M | $107.5M | $58.5M | $34.5M | $27.3M | |
| Gross Profit | $307.1M | $282.8M | $177.4M | $105.7M | $62.2M | |
| Gross Profit Margin | 74.28% | 72.45% | 75.2% | 75.39% | 69.52% | |
| R&D Expenses | $1.2M | $1.1M | $1.3M | $1.1M | $1.1M | |
| Selling, General & Admin | $251.9M | $234.7M | $151.9M | $103.6M | $66.2M | |
| Other Inc / (Exp) | $115K | -$17K | $7K | -$1.9M | -- | |
| Operating Expenses | $251.9M | $234.7M | $151.9M | $103.6M | $66.2M | |
| Operating Income | $55.2M | $48.2M | $25.5M | $2.1M | -$4.1M | |
| Net Interest Expenses | $94K | $261K | -- | -- | -- | |
| EBT. Incl. Unusual Items | $55.2M | $47.9M | $26.5M | $1.6M | -$2.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.2M | $11.7M | $3.4M | $449K | -$396K | |
| Net Income to Company | $42M | $36.2M | $23.1M | $1.1M | -$2.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $42M | $36.2M | $23.1M | $1.1M | -$2.3M | |
| Basic EPS (Cont. Ops) | $3.59 | $3.30 | $2.12 | $0.10 | -$0.21 | |
| Diluted EPS (Cont. Ops) | $3.56 | $3.27 | $2.12 | $0.10 | -$0.21 | |
| Weighted Average Basic Share | $11.7M | $11M | $10.9M | $10.9M | $11M | |
| Weighted Average Diluted Share | $11.8M | $11M | $10.9M | $11M | $11M | |
| EBITDA | $57.8M | $52.5M | $29.9M | $5.3M | -$629K | |
| EBIT | $55.2M | $48.2M | $25.5M | $2.1M | -$4.1M | |
| Revenue (Reported) | $413.4M | $390.4M | $235.9M | $140.2M | $89.4M | |
| Operating Income (Reported) | $55.2M | $48.2M | $25.5M | $2.1M | -$4.1M | |
| Operating Income (Adjusted) | $55.2M | $48.2M | $25.5M | $2.1M | -$4.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.6B | $1.2B | $674.5M | $429.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $364.6M | $454.1M | $338M | $176.7M | $118.4M | |
| Gross Profit | $1B | $1.2B | $880.3M | $497.8M | $311.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.2M | $4.3M | $4.6M | $4.4M | $4.5M | |
| Selling, General & Admin | $841.2M | $986.1M | $717.8M | $486.9M | $317M | |
| Other Inc / (Exp) | -$40K | -$30K | -$54K | -$3.6M | -- | |
| Operating Expenses | $841.2M | $986.1M | $709.3M | $486.9M | $317M | |
| Operating Income | $207.4M | $199M | $171M | $10.8M | -$5.7M | |
| Net Interest Expenses | $161K | $613K | $362K | -- | -- | |
| EBT. Incl. Unusual Items | $207.2M | $198.4M | $151.4M | $12.3M | $2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $49.2M | $47.3M | $31.5M | $5M | $1.8M | |
| Net Income to Company | $158M | $151.1M | $119.9M | $7.3M | $248K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $158M | $151.1M | $119.9M | $7.3M | $248K | |
| Basic EPS (Cont. Ops) | $13.45 | $13.29 | $11.01 | $0.67 | $0.02 | |
| Diluted EPS (Cont. Ops) | $13.34 | $13.19 | $10.97 | $0.67 | $0.02 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $216.7M | $213.2M | $188.6M | $25.9M | $13M | |
| EBIT | $207.4M | $199M | $171M | $10.8M | -$5.7M | |
| Revenue (Reported) | $1.4B | $1.6B | $1.2B | $674.5M | $429.7M | |
| Operating Income (Reported) | $207.4M | $199M | $171M | $10.8M | -$5.7M | |
| Operating Income (Adjusted) | $207.4M | $199M | $171M | $10.8M | -$5.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $881M | $483.5M | $310.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $298.9M | $354.5M | $246.6M | $127.1M | $87.6M | |
| Gross Profit | $849.3M | $906.8M | $634.5M | $356.4M | $223M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3.3M | $3.2M | $3.4M | $3.2M | $3.2M | |
| Selling, General & Admin | $679.9M | $754.6M | $516.8M | $354.2M | $229.5M | |
| Other Inc / (Exp) | $112K | -$37K | -$45K | -$3.5M | $3.1M | |
| Operating Expenses | $679.9M | $754.6M | $516.8M | $354.2M | $229.5M | |
| Operating Income | $169.4M | $152.2M | $117.7M | $2.2M | -$6.4M | |
| Net Interest Expenses | $161K | $520K | $181K | -- | -- | |
| EBT. Incl. Unusual Items | $169.4M | $151.7M | $119M | $2.5M | $744K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $39.4M | $34.6M | $25.6M | $1.2M | $1.3M | |
| Net Income to Company | $130M | $117.1M | $93.4M | $1.3M | -$553K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $130M | $117M | $93.4M | $1.3M | -$553K | |
| Basic EPS (Cont. Ops) | $11.07 | $10.36 | $8.58 | $0.12 | -$0.05 | |
| Diluted EPS (Cont. Ops) | $10.98 | $10.28 | $8.56 | $0.12 | -$0.05 | |
| Weighted Average Basic Share | $35.2M | $33.9M | $32.6M | $32.8M | $32.9M | |
| Weighted Average Diluted Share | $35.5M | $34.1M | $32.7M | $32.9M | $33M | |
| EBITDA | $176.7M | $161.8M | $131M | $12.8M | $4.4M | |
| EBIT | $169.4M | $152.2M | $117.7M | $2.2M | -$6.4M | |
| Revenue (Reported) | $1.1B | $1.3B | $881M | $483.5M | $310.7M | |
| Operating Income (Reported) | $169.4M | $152.2M | $117.7M | $2.2M | -$6.4M | |
| Operating Income (Adjusted) | $169.4M | $152.2M | $117.7M | $2.2M | -$6.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $174.5M | $109.5M | $87.7M | $150M | $162.3M | |
| Short Term Investments | $10.8M | $5.4M | -- | $55.6M | $71.4M | |
| Accounts Receivable, Net | $584K | -- | -- | -- | -- | |
| Inventory | $53.4M | $180M | $118.9M | $54.6M | $42.4M | |
| Prepaid Expenses | -- | $945K | -- | $8.7M | -- | |
| Other Current Assets | -- | $16.3M | $16.2M | $10.7M | -- | |
| Total Current Assets | $234.3M | $306.9M | $222.8M | $224M | $214.4M | |
| Property Plant And Equipment | $38.1M | $80.6M | $75.6M | $67.1M | $48.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.9M | $6.5M | $12.5M | $14.7M | $9.7M | |
| Total Assets | $283.8M | $412.5M | $332.8M | $326.3M | $293.2M | |
| Accounts Payable | $35.8M | $70.9M | $58.7M | $39.2M | $23.1M | |
| Accrued Expenses | $24.6M | $35.9M | $23.8M | $22.1M | $14M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.7M | $6.5M | $5.8M | $5.9M | $6.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $111.4M | $169.8M | $140.9M | $92.3M | $64.2M | |
| Long-Term Debt | $7.5M | $26M | $20.3M | $16.1M | $9.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $126.6M | $210M | $177.7M | $124.8M | $83.1M | |
| Common Stock | $12K | $12K | $11K | $11K | $11K | |
| Other Common Equity Adj | $41K | $111K | $24K | $248K | $180K | |
| Common Equity | $157.2M | $202.5M | $155M | $201.5M | $210.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $157.2M | $202.5M | $155M | $201.5M | $210.1M | |
| Total Liabilities and Equity | $283.8M | $412.5M | $332.8M | $326.3M | $293.2M | |
| Cash and Short Terms | $174.5M | $109.5M | $87.7M | $150M | $162.3M | |
| Total Debt | $7.5M | $26M | $20.3M | $16.1M | $9.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $159.9M | $69.7M | $157.8M | $170M | $173.5M | |
| Short Term Investments | $5.4M | -- | $45M | $54.6M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $129.6M | $145.3M | $58.2M | $40.1M | $23.2M | |
| Prepaid Expenses | -- | $150K | -- | $8.2M | $4.3M | |
| Other Current Assets | -- | -- | $8.3M | $6.7M | -- | |
| Total Current Assets | $301.1M | $229.6M | $224.3M | $225M | $207.8M | |
| Property Plant And Equipment | $63.2M | $77.9M | $69.2M | $51.3M | $41.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $6.4M | $12.7M | $15.8M | $11M | -- | |
| Total Assets | $371.4M | $326.4M | $320M | $291.2M | $268.2M | |
| Accounts Payable | $155.5M | $148.1M | $103.2M | $66.3M | $41.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $5.4M | $6.1M | $5.5M | $6.1M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $160.9M | $154.3M | $110.1M | $72.4M | $46.7M | |
| Long-Term Debt | $14.2M | $21.6M | $16.9M | $11.5M | $6.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $175.1M | $175.8M | $127M | $83.9M | $53.5M | |
| Common Stock | $12K | $11K | $11K | $11K | $11K | |
| Other Common Equity Adj | $122K | $391K | $141K | $349K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $196.2M | $150.5M | $193M | $207.3M | $214.7M | |
| Total Liabilities and Equity | $371.4M | $326.4M | $320M | $291.2M | $268.2M | |
| Cash and Short Terms | $159.9M | $69.7M | $157.8M | $170M | $173.5M | |
| Total Debt | $14.2M | $21.6M | $16.9M | $11.5M | $6.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Depreciation & Amoritzation | $7.3M | $11.9M | $17.1M | $17.7M | $12.7M | |
| Stock-Based Compensation | $6.8M | $9.9M | $11.1M | $8.2M | $7.4M | |
| Change in Accounts Receivable | $297K | -- | -- | -- | -- | |
| Change in Inventories | -$4.6M | -$126.7M | $61.2M | $64.3M | $12.2M | |
| Cash From Operations | $145.2M | $94.5M | $194.6M | $147.7M | $24.5M | |
| Capital Expenditures | $5.9M | $34.2M | $16.7M | $6.5M | $7.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.3M | -$29.1M | -$11.4M | -$61M | -$26.5M | |
| Dividends Paid (Ex Special Dividend) | $53.2M | $63.9M | $71.6M | $73M | $715K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $5.6M | $62.1M | $128M | $7M | $836K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$57.1M | -$125.1M | -$199.6M | -$79.8M | -$1.5M | |
| Beginning Cash (CF) | $163.7M | $104.2M | $87.7M | $94.4M | $90.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $86.7M | -$59.5M | -$16.5M | $6.7M | -$3.5M | |
| Ending Cash (CF) | $250.5M | $44.8M | $71.1M | $101.1M | $87.5M | |
| Levered Free Cash Flow | $139.3M | $60.3M | $177.9M | $141.2M | $17M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $42M | $36.2M | $23.1M | $1.1M | -$2.3M | |
| Depreciation & Amoritzation | $2.6M | $7.6M | $4.4M | $3.2M | $3.5M | |
| Stock-Based Compensation | $2.3M | $3M | $2.7M | $606K | $910K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$33.8M | $11.7M | $10.7M | -$492K | $7M | |
| Cash From Operations | $15.8M | $55.4M | $29.9M | $9.1M | $12.1M | |
| Capital Expenditures | $10.4M | $1.8M | $1.7M | $1.4M | $1.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$10.4M | -$1.8M | -$46.5M | -$1.8M | -$14.3M | |
| Dividends Paid (Ex Special Dividend) | $16.8M | $18.1M | $18M | $1K | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -$27M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $26.3M | $25K | $110K | $2K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$42.9M | -$45.1M | -$18.2M | -$3K | -- | |
| Beginning Cash (CF) | $154.5M | $69.7M | $112.8M | $115.3M | $99.5M | |
| Foreign Exchange Rate Adjustment | $63K | $119K | $26K | $4K | -- | |
| Additions / Reductions | -$37.5M | $8.6M | -$34.7M | $7.3M | -$2.2M | |
| Ending Cash (CF) | $117.1M | $78.5M | $78.1M | $122.6M | $97.4M | |
| Levered Free Cash Flow | $5.4M | $53.6M | $28.3M | $7.7M | $10.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $158M | $151.1M | $119.9M | $7.3M | $248K | |
| Depreciation & Amoritzation | $9.3M | $17.4M | $17.6M | $14M | $14M | |
| Stock-Based Compensation | $9.2M | $11.4M | $8.7M | $7.6M | $7.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$87.9M | -$15.7M | $87.1M | $18.1M | $16.9M | |
| Cash From Operations | $121.8M | $135.4M | $188.9M | $39.9M | $7.2M | |
| Capital Expenditures | $24.6M | $19.2M | $14.6M | $6.1M | $6.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$16.9M | -$14M | -$59.4M | -$17.8M | -$22.4M | |
| Dividends Paid (Ex Special Dividend) | $60.1M | $70.7M | $73M | $18.7M | $195K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $47.9M | $135.8M | $13.4M | $845K | $371K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$107M | -$206.5M | -$86.2M | -$19.4M | -$566K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2M | -$84.8M | $43M | $2.6M | -$15.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $97.2M | $116.1M | $174.3M | $33.8M | $646K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $130M | $117.1M | $93.4M | $1.3M | -$553K | |
| Depreciation & Amoritzation | $7.3M | $12.8M | $13.3M | $9.5M | $10.8M | |
| Stock-Based Compensation | $6.6M | $8.1M | $5.8M | $5.2M | $5.5M | |
| Change in Accounts Receivable | $496K | -- | -- | -- | -- | |
| Change in Inventories | -$76.2M | $34.8M | $60.6M | $14.5M | $19.2M | |
| Cash From Operations | $102M | $142.8M | $137.1M | $29.4M | $12.1M | |
| Capital Expenditures | $22.6M | $7.6M | $5.5M | $5.2M | $4.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$17.4M | -$2.4M | -$50.3M | -$7.1M | -$3M | |
| Dividends Paid (Ex Special Dividend) | $46.8M | $53.7M | $55M | $715K | $195K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $47.9M | $121.6M | $7M | $835K | $370K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$93.9M | -$175.3M | -$61.9M | -$1.5M | -$565K | |
| Beginning Cash (CF) | $552.5M | $248.8M | $383.9M | $320.8M | $292.9M | |
| Foreign Exchange Rate Adjustment | $130K | $296K | $125K | $47K | -- | |
| Additions / Reductions | -$9.2M | -$34.5M | $25.1M | $20.9M | $8.6M | |
| Ending Cash (CF) | $543.5M | $214.6M | $409.1M | $341.7M | $301.5M | |
| Levered Free Cash Flow | $79.4M | $135.2M | $131.6M | $24.3M | $7.9M | |
Related Companies
Get MED Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MED
Sector
P/E ratio
533.49x
16.77x
PEG ratio
--
0.13x
P/B ratio
0.57x
1.48x
Price / LTM sales
0.29x
0.51x
Growth Metrics
MED
Sector
Revenue growth
-36.21%
2.99%
Earnings growth
-299.9%
5%
Revenue (5-year growth)
-3.33%
3.31%
Earnings forecast
-$0.36
$0.32
Profitability
MED
Sector
Profitability FY 2024
$444.6M
$260.8M
Return on invested capital
0.11%
4.37%
Return on assets
0.09%
3.07%
Return on equity
0.12%
7.5%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Feb
2
Balance Sheet
MED
Sector
Total cash
$173.5M
$87.3M
Short term investments
$71.4M
$32.9M
Total assets
$293.2M
$1.1B
Long term debt
$6.8M
$6.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
